Myopathic causes of exercise intolerance with rhabdomyolysis

Developmental Medicine and Child Neurology

Volumn 54, Issue 10, 2012, Pages 886-891

  Quinlivan, Ros ^a,b   Jungbluth, Heinz ^c,d  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATINE KINASE; RYANODINE RECEPTOR 1;

BECKER MUSCULAR DYSTROPHY; BLOOD PRESSURE; CENTRAL CORE DISEASE; CENTRONUCLEAR MYOPATHY; CREATINE KINASE BLOOD LEVEL; DISORDERS OF CARBOHYDRATE METABOLISM; DNA DETERMINATION; DUCHENNE MUSCULAR DYSTROPHY; EXERCISE; FATTY ACID OXIDATION; FLUID INTAKE; GENE DELETION; GENETIC ANALYSIS; GLYCOGEN METABOLISM; GLYCOGEN STORAGE DISEASE TYPE 5; HEAT INTOLERANCE; HEAT STROKE; HUMAN; HYPERKALEMIA; HYPOCALCEMIA; LEG PAIN; LIMB GIRDLE MUSCULAR DYSTROPHY; MALIGNANT HYPERTHERMIA; MASS SPECTROMETRY; MOLECULAR DIAGNOSIS; MULTIMINICORE DISEASE; MUSCLE CRAMP; MUSCLE ISOMETRIC CONTRACTION; MUSCULAR DYSTROPHY; MYALGIA; MYOGLOBINURIA; MYOPATHY; NAUSEA AND VOMITING; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS;

ALGORITHMS; CHILD; DIAGNOSIS, DIFFERENTIAL; EXERCISE TEST; EXERCISE TOLERANCE; HUMANS; METABOLISM, INBORN ERRORS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUSCLE CRAMP; MUSCULAR DYSTROPHIES; RHABDOMYOLYSIS;

EID: 84866403199     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2012.04320.x     Document Type: Review

References (40)

1. Garrood P, Eagle M, Jardine PE, Bushby K, Straub V. Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy. Neuromuscul Dis 2008; 18: 71-3.
2. Minetti C, Tanji K, Chang HW, et al. Dystrophinopathy in two young boys with exercise-induced cramps and myoglobinuria. Eur J Pediatr 1993; 152: 848-51.
3. Figarella-Branger D, Baeta Machado AM, Putzu GA, Malzac P, Voelckel MA, Pellissier JF. Exertional rhabdomyolysis and exercise intolerance revealing dystrophinopathies. Acta Neuropathol 1997; 94: 48-53.
4. Itagaki Y, Saida K, Nishitani H, Matsuo M, Nishio H. [Manifesting carriers of Duchenne muscular dystrophy over two generations] (In Japanese). Rinsho Shinkeigaku 1993; 33: 377-81.
5. Mathews KD, Stephan C, Laubenthal K, et al. Myoglobinuria and muscle pain are common in patients with limb-girdle muscular dystrophy 2I. Neurology 2011; 76: 194-5.
6. D'Amico A, Petrini S, Parisi F, et al. Heart transplantation in a child with LGMD2I presenting as isolated dilated cardiomyopathy. Neuromuscul Disord 2008; 18: 153-5.
7. Walsh R, Hill F, Breslin N, et al. Progressive dysphagia in limb-girdle muscular dystrophy type 2B. Muscle Nerve 2011; 43: 761-4.
8. Nguyen K, G Bassez, Krahn M, et al. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol 2007; 64: 1176-82.
9. Löfberg M, Jänkälä H, Paetau A, Härkönen M, Somer H. Metabolic causes of recurrent rhabdomyolysis. Acta Neurol Scand 1998; 98: 268-75.
10. Pena L, Kim K, Charrow J. Episodic myoglobinuria in a primary gamma-sarcoglycanopathy. Neuromuscul Disord 2010; 20: 337-9.
11. Cagliani R, Comi GP, Tancredi L, et al. Primary beta-sarcoglycanopathy manifesting as recurrent exercise-induced myoglobinuria. Neuromuscul Disord 2001; 11: 389-94.
12. Milone M, Liewluck T, Winder TL, Pianosi PT. Amyloidosis and exercise intolerance in ANO5 muscular dystrophy. Neuromuscul Disord 2012; 22: 13-5.
13. Rubio JC, Lucia A, Fernandez-Cadenas I, et al. Novel mutation in the PYGM gene resulting in McArdle disease. Arch Neurol 2006; 63: 1782-4.
14. Quinlivan R, Buckley J, James M, et al. McArdle disease: a clinical review. J Neurol Neurosurg Psychiatry 2010; 81: 1182-8.
15. Haller RG, Wyrick P, Taivassalo T, Vissing J. Aerobic conditioning: an effective therapy in McArdle's disease. Ann Neurol 2006; 59: 922-8.
16. Haller RG, Vissing J. Spontaneous 'second wind' and glucose-induced second 'second wind' in McArdle disease: oxidative mechanisms. Arch Neurol 2002; 59: 1395-402.
17. Moerman P, Lammens M, Fryns JP, Lemmens F, Lauweryns JM. Fetal akinesia sequence caused by glycogenosis type VII. Genet Couns 1995; 6: 15-20.
18. Toscano A, Musumeci O. Tarui disease and distal glycogenoses: clinical and genetic update. Acta Myol 2007; 26: 105-7.
19. Haller RG, Vissing J. No spontaneous second wind in muscle phosphofructokinase deficiency. Neurology 2004; 62: 82-6.
20. Kreuder J, Borkhardt A, Repp R, et al. Brief report: inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. N Engl J Med 1996; 334: 1100-4.
21. Thuiller L, Rostane H, Droin V, et al. Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 deficiency. Hum Mutat 2003; 5: 493-501.
22. Olsen RK, Dobrowolski SF, Kjeldsen M, et al. High-resolution melting analysis, a simple and effective method for reliable mutation scanning and frequency studies in the ACADVL gene. J Inherit Metab Dis 2010; 33: 247-60.
23. Ficicioglu C, Coughlin CR 2nd, Bennett MJ, Yudkoff M. Very long-chain acyl-CoA dehydrogenase deficiency in a patient with normal newborn screening by tandem mass spectrometry. J Pediatr 2010; 156: 492-4.
24. Ter Veld F, Mueller M, Kramer S, et al. A novel tandem mass spectrometry method for rapid confirmation of medium- and very long-chain acyl-CoA dehydrogenase deficiency in newborns. PLoS ONE 2009; 4: e6449.
25. Andresen BS, Olpin S, Poorthuis BJ, et al. Clear correlation of genotype with disease phenotype in very long chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet 1999; 64: 479-94.
26. Bonnefont JP, Bastin J, Laforet P, et al. Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency. J Inherit Metab Dis 2010; 30: 405.
27. Zeharai A, Shaag A, Hootkooper RH, et al. Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. Am J Hum Genet 2008; 83: 489-94.
28. Durham WJ, Wehrens XH, Sood S, Hamilton SL. Diseases associated with altered ryanodine receptor activity. Subcell Biochem 2007; 45: 273-321.
29. Jungbluth H. Central core disease. Orphanet J Rare Dis 2007; 2: 25.
30. Quinlivan RM, Muller CR, Davis M, et al. Central core disease: clinical, pathological, and genetic features. Arch Dis Child 2003; 88: 1051-5.
31. Romero NB, Monnier N, Viollet L, et al. Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia. Brain 2003; 126: 2341-9.
32. Jungbluth H, Sewry CA, Muntoni F. What's new in neuromuscular disorders? The congenital myopathies. Eur J Paediatr Neurol 2003; 7: 23-30.
33. Wilmshurst JM, S Lillis, Zhou H, et al. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol 2010; 68: 717-26.
34. Bethlem J, van Gool J, Hulsmann WC, Meijer AE. Familial non-progressive myopathy with muscle cramps after exercise. A new disease associated with cores in the muscle fibres. Brain 1966; 89: 569-88.
35. Wappler F, Fiege M, Steinfath M, et al. Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis. Anesthesiology 2001; 94: 95-100.
36. Davis M, Brown R, Dickson A, et al. Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees. Br J Anaesth 2002; 88: 508-15.
37. Capacchione JF, Sambuughin N, Bina S, Mulligan LP, Lawson TD, Muldoon SM. Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms. Anaesthesiology 2010; 112: 239-44.
38. Sambuughin N, Capacchione J, Blokhin A, Bayarsaikhan M, Bina S, Muldoon S. The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility. Clin Genet 2009; 76: 564-8.
39. Yu FC, Lu KC, Lin SH, et al. Energy metabolism in exertional heat stroke with acute renal failure. Nephrol Dial Transplant 1997; 12: 2087-92.
40. Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med 2010; 48: 749-56.